arginine has been researched along with Diabetic Glomerulosclerosis in 115 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (4.35) | 18.7374 |
| 1990's | 30 (26.09) | 18.2507 |
| 2000's | 39 (33.91) | 29.6817 |
| 2010's | 32 (27.83) | 24.3611 |
| 2020's | 9 (7.83) | 2.80 |
| Authors | Studies |
|---|---|
| Brunengraber, H; Cushman, M; Feldman, HI; Gutiérrez, OM; Hostetter, TH; Ix, JH; Katz, R; Kimmel, PL; Rhee, EP; Sapa, H; Sarnak, MJ; Schelling, JR; Schrauben, SJ; Seegmiller, JC; Shlipak, MG; Vasan, RS | 1 |
| Cao, P; Cao, R; Cao, Y; Chi, C; Hong, M; Huang, B; Jiang, Y; Li, S | 1 |
| Anderson, AH; Bhat, Z; Brown, J; Brunengraber, H; Charleston, J; Chen, J; Feldman, HI; He, J; Hostetter, TH; Hsu, CY; Ix, JH; Kimmel, PL; Mehta, R; Rao, P; Sapa, H; Schelling, JR; Schrauben, SJ; Seegmiller, JC; Shafi, T; Shlipak, MG; Townsend, R; Vasan, RS; Xie, D; Zhang, X | 1 |
| Balint, L; Bob, F; Cretu, OM; Gadalean, F; Glavan, M; Ienciu, S; Jianu, DC; Milas, O; Mogos, M; Petrica, L; Socaciu, AI; Socaciu, C; Suteanu-Simulescu, A; Vlad, A | 1 |
| Bian, B; Gao, C; Gao, S; Gao, W; Li, T; Liu, Y; Sato, T; Si, N; Wang, H; Wang, M; Wei, X; Zhang, Y; Zhao, H; Zhao, W; Zhou, Y | 1 |
| Bode-Böger, SM; Brilloff, S; Hohenstein, B; Hugo, C; Jarzebska, N; Martens-Lobenhoffer, J; Rexin, A; Rodionov, RN; Schneider, A; Sradnick, J; Todorov, V; Weiss, N | 1 |
| Awad, AS; Cooper, TK; Gao, T; Morris, SM; Stanley, K; Wetzel, MD | 1 |
| Bhattacharya, N; Ghanate, A; Kannan, S; Kuppan, G; Manickam, N; Mohan, V; Panchagnula, V; Pandey, GK; Parmar, D; Prabu, P; Pramodkumar, TA; Ragi, NC; Sripadi, P; Vadivel, S | 1 |
| Atan, D; Barrington, AF; Butler, MJ; Coward, RJM; Graham, M; Heesom, KJ; Herbert, E; Hurcombe, JA; Ju, W; Kretzler, M; Lay, AC; Lewis, PA; McArdle, CA; Mountjoy, E; Nair, V; Neal, CR; Nelson, RG; Perrett, RM; Ramnath, RD; Satchell, SC; Welsh, GI; Wilson, MC | 1 |
| Correa-Giannella, MLC; Lira, ALA; Minanni, CA; Nakandakare, ER; Passarelli, M; Pinto, RS; Queiroz, MS; Ronsein, GE; Santana, MFM; Sawada, MIBAC; Silva, ARM | 1 |
| Balasubramanyam, M; Jayachandran, I; Manickam, N; Mohan, V; Paramasivam, P; Subramanian, SC; Sundararajan, S; Venkatesan, B | 1 |
| Bode-Böger, SM; Brilloff, S; Heinrich, A; Hohenstein, B; Hugo, CPM; Jarzebska, N; Martens-Lobenhoffer, J; Rodionov, RN; Todorov, VT; Weiss, N | 1 |
| Nakaya, I; Nakayama, K; Nakayama, M; Soma, J; Tezuka, Y; Yahata, M | 1 |
| Chen, W; He, K; Li, C; Liu, J; Ma, B; Ma, H; Tian, L; Zhao, P | 1 |
| Chen, YY; He, LY; Liu, GY; Liu, H; Liu, JS; Peng, XF; Sun, L; Xiao, L | 1 |
| Ando, R; Fukami, K; Kaida, Y; Kaifu, K; Miyazaki, H; Nakayama, Y; Obara, N; Okuda, S; Takeuchi, M; Ueda, S; Yamagishi, S; Yokoro, M | 1 |
| Hedayati, M; Hosseinpanah, F; Nafar, M; Noori, N; Tabibi, H | 1 |
| Agilli, M; Avci, E; Bilgi, C; Cakir, E; Cevher, SC; Yaman, H | 1 |
| Hirade, R; Mihara, T; Nikai, T; Ota, J; Saito, Y; Sakakibara, S | 1 |
| Fasching, A; Hansell, P; Palm, F; Persson, P; Teerlink, T | 1 |
| Ahmad, K; Ahmad, S; Akhter, F; Khan, MS; Saeed, M; Shahab, U; Srivastava, AK; Tabrez, S | 1 |
| Awad, AS; Cooper, TK; Gao, T; Morris, SM; You, H | 1 |
| Bob, F; Dumitrascu, V; Gadalean, F; Gluhovschi, C; Gluhovschi, G; Jianu, DC; Petrica, L; Petrica, M; Popescu, R; Ursoniu, S; Velciov, S; Vlad, A; Vlad, D | 1 |
| Jing, Z; Kuang, L; Liu, N; Yang, J | 1 |
| Aycan-Ustyol, E; Bekpinar, S; Dinccag, N; Gurdol, F; Unlucerci, Y; Yenidunya, G | 1 |
| Borsos, AM; M'bemba, J; Peyroux, J; Selam, JL; Slama, G; Sternberg, M; Urios, P | 1 |
| Aoki, T; Funabiki, K; Gohda, T; Gotoh, H; Matsumoto, M; Moon, JY; Ohsawa, I; Shibata, T; Tanimoto, M; Tomino, Y | 1 |
| Aso, Y | 1 |
| Fukami, K; Hayashida, A; Kaida, Y; Kato, S; Kimoto, M; Matsumoto, Y; Matsuoka, H; Okuda, S; Shibata, R; Ueda, S; Yamagishi, S | 1 |
| Babazono, T; Hanai, K; Ishii, A; Iwamoto, Y; Nyumura, I; Tanaka, M; Tanaka, N; Toya, K | 1 |
| Amin, R; Dalton, RN; Dunger, DB; Marcovecchio, ML; Prevost, AT; Turner, C; Widmer, B | 1 |
| Arellano-Mendoza, MG; Castorena-Torres, F; Coronel, I; del Valle-Mondragon, L; Escalante, B; Rios, A; Romo, E; Vargas-Robles, H | 1 |
| Erhard, P; Genuth, S; Kern, EF; Sun, W; Weiss, MF | 1 |
| Axelsson, J; Caglar, K; Cayci, T; Eyileten, T; Kilic, S; Oguz, Y; Saglam, M; Sonmez, A; Vural, A; Yaman, H; Yenicesu, M; Yilmaz, MI | 1 |
| Avogaro, A; Cecchet, D; Coracina, A; Cosma, A; Iori, E; Millioni, R; Puricelli, L; Tessari, P; Vedovato, M; Vettore, M | 1 |
| Aiello, LP; Asztalos, BF; Cavallerano, JD; Doria, A; Keenan, HA; King, GL; Monnier, VM; Schaefer, EJ; Sell, DR; Strauch, CM; Sun, JK | 1 |
| Arya, A; Sharma, PL; Yadav, HN | 1 |
| Matsui, T; Yamagishi, S | 1 |
| Ishii, M; Miyazaki, A; Sanaka, T | 1 |
| Adaikalakoteswari, A; Ficociello, LH; Krolewski, AS; Niewczas, M; Perkins, BA; Rabbani, N; Thornalley, P; Warram, J; Weston, A | 1 |
| Lin, CY; Yin, MC | 1 |
| Cheng, H; Fan, X; Harris, RC; Paueksakon, P; Wang, H | 1 |
| Ben Yahia, S; Bouzidi, H; Hammami, M; Kerkeni, M; Letaief, A; Saïdi, A | 1 |
| Bartáková, V; Bělobrádková, J; Jurajda, M; Kaňková, K; Klepárník, M; Krusová, D; Kuricová, K; Malúšková, D; Mužík, J; Olšovský, J; Pácal, L; Pavlík, T; Rehořová, J; Stěpánková, S; Svojanovský, J; Tanhäuserová, V; Tomandl, J | 1 |
| Fukami, K; Ishibashi, Y; Maeda, S; Matsui, T; Nishino, Y; Ojima, A; Takeuchi, M; Yamagishi, S | 1 |
| Erley, CM; Friedrich, B; Heyne, N; Osswald, H; Schmidt, T; Strobel, U; Wehrmann, M | 1 |
| Adachi, T; Fukui, M; Hara, H; Hasegawa, G; Kimura, F; Kitagawa, Y; Nakamura, N; Nakano, K; Obayashi, H; Ohta, M; Park, H; Yoshikawa, T | 1 |
| Bárány, P; Heimburger, O; Hoff, CM; Holmes, CJ; Lindholm, B; Marchlewska, A; Nordfors, L; Pecoits-Filho, R; Schalling, M; Stenvinkel, P; Suliman, M | 1 |
| Inagi, R; Ishikawa, N; Koike, H; Kurokawa, K; Miyata, T; Mizuno, M; Nangaku, M; Sada, T; Ueda, Y; van Ypersele de Strihou, C; Yuzawa, H | 1 |
| Hovind, P; Parving, HH; Stehouwer, CD; Tarnow, L; Teerlink, T | 1 |
| Klahr, S; Morrissey, J | 1 |
| Aso, Y; Inukai, T; Sekine, K; Takanashi, K; Takebayashi, K; Yoshida, N; Yoshihara, K | 1 |
| Hirata, K; Kubo, K | 1 |
| Balkau, B; Besmond, C; Danze, PM; Fajardy, I; Fontaine, P; Marre, M; Prevost, G; Tichet, J | 1 |
| Bassal, S; Cooper, ME; Deemer, ER; El-Osta, A; Forbes, JM; Jerums, G; Long, DM; Osicka, TM; Panagiotopoulos, S; Pete, J; Thallas-Bonke, V; Thomas, MC; Thorpe, SR | 1 |
| Hosokawa, T; Sanaka, T | 1 |
| Alwahdani, A; Chu, Y; Faraci, FM; Heistad, DD; Iida, S; Lund, DD | 1 |
| Chetyrkin, SV; Chuang, P; Ham, AJ; Hudson, BG; Mathieson, PW; Pedchenko, VK; Saleem, MA; Voziyan, PA | 1 |
| Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Nangaku, M; Shibata, T; Sugiyama, S; Usuda, N; van Ypersele de Strihou, C | 1 |
| Böger, RH; Maas, R; Quispe-Bravo, S; Schwedhelm, E; Skamira, C | 1 |
| Słowik-Zyłka, D | 1 |
| Aso, Y; Yamamoto, R | 1 |
| Higuchi, M; Hora, K; Kamijo, H | 1 |
| Bellinghieri, G; De Luca, G; Di Giorgio, RM; Mallamace, A; Santoro, D; Savica, V | 1 |
| Etmüller, Y; Hofer, M; Kapiotis, S; Krzyzanowska, K; Mittermayer, F; Schernthaner, G; Schnabler, J; Shnawa, N; Wolzt, M | 1 |
| Chang, JW; Chun, S; Kim, SB; Kim, TH; Lee, EK; Lee, KU; Min, WK; Park, JS | 1 |
| Busch, M; Franke, S; Stein, G; Wolf, G | 1 |
| Carlsson, PO; Friederich, M; Hansell, P; Liss, P; Palm, F; Teerlink, T | 1 |
| Izuhara, Y; Miyata, T; Nangaku, M; Ohtomo, S; Strihou, Cv; Takizawa, S | 1 |
| Jorsal, A; Lajer, M; Parving, HH; Rossing, P; Tarnow, L; Teerlink, T | 1 |
| Calabrese, V; Calafato, S; Castellino, P; Cornelius, C; Di Mauro, M; Finocchiaro, M; Mancuso, C; Mangiameli, A; Puleo, E; Sapienza, M; Stella, AM | 1 |
| Busch, M; Franke, S; Rohde, RD; Stein, G; Wolf, G | 1 |
| Böger, RH; Galle, J; Pinnetti, S; Schwedhelm, E; Wanner, C | 1 |
| Hansen, AP; Hansen, HE; Orskov, H; Schmitz, O | 1 |
| Alberti, KG; Hansen, AP; Hansen, HE; Orskov, H; Schmitz, O | 1 |
| Denda, M; Inoue, T; Ishihara, C; Kushida, K; Takahashi, M | 1 |
| Friedlander, MA; Hricik, DE; Monnier, VM; Schulak, JA; Wu, YC | 1 |
| Allen, TJ; Cooper, ME; Komers, R | 1 |
| Burcharth, F; Christiansen, E; Madsbad, S; Rasmussen, K; Tibell, A; Tydén, G | 1 |
| Karl, IE; Kissane, J; Klahr, S; Reyes, AA | 1 |
| Beisswenger, PJ; Brinck-Johnsen, T; Curphey, TJ; Moore, LL | 1 |
| Fogarty, JF; Hricik, DE; Monnier, VM; Schulak, JA; Sell, DR | 1 |
| Bailie, KE; Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; McCance, DR; Thorpe, SR | 1 |
| Ritz, E | 1 |
| Iida, Y; Kurokawa, K; Maeda, K; Miyata, T; Shinzato, T; Tanaka, S; Ueda, Y; van Ypersele de Strihou, C | 1 |
| Blum, M; Cabili, S; Chernihovsky, T; Goor, Y; Iaina, A; Peer, G; Silverberg, D; Wollman, Y | 1 |
| Amann, G; Aufricht, C; Höger, H; Kitzmüller, E; Lubec, B | 1 |
| Horie, K; Iida, Y; Maeda, K; Miyata, T; Sugiyama, S; Tanaka, H; Tsuyuki, M | 1 |
| Hayase, F; Ishizaki, Y; Katsuzaki, T; Miyazaki, S; Miyazaki, T; Niwa, T; Takei, Y; Tatemichi, N | 1 |
| Blanco, MC; Camejo, M; Contreras, I; Giansante, E; Gonzalez, F; Lopez, T; Martinez, N; Molina, M; Postalian, S; Reiser, KM; Sanchez, MR; Suarez, N | 1 |
| Hayase, F; Ishizaki, Y; Katsuzaki, T; Miyazaki, T; Niwa, T; Takei, Y; Tatemichi, N; Uematsu, T | 1 |
| Crimmins, DL; Futterweit, S; Trachtman, H | 1 |
| Izumi, G; Kobayashi, N; Kumano, K; Sakai, T; Shibata, K; Wang, H; Yokota, S; Yoshida, A; Yoshihara, T | 1 |
| Horie, K; Kurokawa, K; Maeda, K; Miyata, S; Miyata, T; Monnier, VM; Sakai, H; Sugiyama, S; van Ypersole de Strihou, C; Witztum, JL | 1 |
| Bagdade, JD; Eckel, RH; Ritter, MC; Robertson, RP; Teuscher, AU | 1 |
| Hricik, DE; Justice, AC; Rodby, RA; Weiss, MF | 1 |
| Kawashima, S; Kurokawa, K; Maeda, K; Miyata, T; Sugiyama, S; Tanaka, H; Ueda, Y; Van Ypersele de Strihou, C | 1 |
| Kogure, A; Kondo, M; Nakamura, Y; Sakane, N; Takakura, Y; Umekawa, T; Yoshida, T; Yoshioka, K | 1 |
| Klahr, S | 1 |
| Aoyama, I; Katsuzaki, T; Miyazaki, T; Niwa, T; Shimokata, K; Takayama, F; Tsukushi, S | 1 |
| Daimon, M; Eguchi, H; Hirata, A; Igarashi, M; Kato, T; Manaka, H; Ohnuma, H; Ono, Y; Saito, T; Yamaguchi, H | 1 |
| Grzeszczak, W; Labuz, B; Lacka, B; Saucha, W; Szydlowska, I; Zukowska-Szczechowska, E; Zychma, MJ | 1 |
| Baba, T; Nakajima, S | 1 |
| D'Agati, VD; Fu, C; Kislinger, T; Markowitz, GS; Pischetsrieder, M; Schmidt, AM; Stern, D; Taguchi, A; Tanji, N | 1 |
| Aricó, CN; Bernich, P; Fedele, D; Gammaro, L; Lapolla, A; Tessitore, N | 1 |
| Beck, W; Deppisch, RM; Pommer, W; Riedel, E; Schröder, M | 1 |
| Prabhakar, SS | 1 |
| Bakala, H; Depreux, P; Fourmaintraux, E; Schwedler, SB; Striker, GE; Striker, LJ; Verbeke, P; Vilar, J; Weiss, MF | 1 |
| Antolini, F; Buoncristiani, U; Fagugli, RM; Floridi, A; Floridi, E; Galli, F | 1 |
| Mogensen, CE | 1 |
| Fogarty, J; Lapolla, A; Monnier, VM; Odetti, P; Sell, DR | 1 |
| Caldara, R; Di Carlo, V; La Rocca, E; Martinenghi, S; Pozza, G; Secchi, A | 1 |
| Dubernard, JM; La Rocca, E; LeFrancois, N; Martin, X; Melandri, M; Pozza, G; Secchi, A; Touraine, JL; Traeger, J | 1 |
| Aguilar-Parada, E; Eisentraut, AM; Müller, WA; Unger, RH | 1 |
| Novelli, E; Pinacci, U | 1 |
10 review(s) available for arginine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis.
Topics: Arginine; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Humans; Male; Risk Factors | 2019 |
Cardiovascular disease in patients with diabetic nephropathy.
Topics: Anemia; Arginine; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Enzyme Inhibitors; Glycation End Products, Advanced; Homocysteine; Humans; Prognosis; Risk Factors | 2008 |
Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy-Friend or foe?
Topics: Animals; Arginine; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Nitric Oxide; Nitric Oxide Synthase Type II | 2011 |
L-arginine as a therapeutic tool in kidney disease.
Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Humans; Kidney Diseases; Nitric Oxide; Prognosis; Rats; Renal Circulation; Risk Assessment; Treatment Outcome; Up-Regulation | 2004 |
[Measurement of plasma pentosidine and the clinical significance in diagnosis of diabetic nephropathies].
Topics: Arginine; Biomarkers; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Lysine; Male; Oxidative Stress; Reagent Kits, Diagnostic; ROC Curve; Sensitivity and Specificity | 2005 |
L-arginine: a new opportunity in the management of clinical derangements in dialysis patients.
Topics: Adult; Aged; Animals; Arginine; Citrulline; Diabetic Nephropathies; Endothelium, Vascular; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide; Renal Dialysis | 2006 |
Why are lipids not predictive of cardiovascular death in the dialysis patient?
Topics: Apolipoproteins B; Arginine; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Heart Diseases; Humans; Lipoprotein(a); Nutrition Disorders; Predictive Value of Tests; Renal Dialysis; Risk Assessment; Survival Rate | 1996 |
Advanced glycation end-products in diabetic nephropathy.
Topics: Animals; Arginine; Blood Glucose; Diabetic Nephropathies; Glycation End Products, Advanced; Glycosylation; Humans; Immunohistochemistry; Lysine; Norleucine; Proteins; Pyrroles | 1996 |
Can L-arginine manipulation reduce renal disease?
Topics: Animals; Arginine; Diabetic Nephropathies; Glomerulonephritis; Humans; Kidney Diseases; Nephrectomy; Nitric Oxide; Rats; Ureteral Obstruction | 1999 |
Hemodialysis techniques and advanced glycation end products.
Topics: Arginine; Blood Proteins; Chromatography, High Pressure Liquid; Diabetic Nephropathies; Glycation End Products, Advanced; Hemodiafiltration; Hemodialysis Solutions; Hemofiltration; Humans; Kidney Failure, Chronic; Lysine; Membranes, Artificial; Molecular Weight; Renal Dialysis; Ultrafiltration; Uremia | 2001 |
9 trial(s) available for arginine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.
Topics: Adult; Aged; Albuminuria; Arginine; Blood Pressure; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyridoxine; Thioctic Acid | 2013 |
[Reduction of carbonyl stress with renal replacement therapy in chronic renal failure].
Topics: Adult; Arginine; Body Mass Index; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Oxidative Stress; Renal Dialysis; Treatment Outcome; Ultrafiltration | 2004 |
Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study.
Topics: Adult; Antioxidants; Arginine; Biomarkers; C-Reactive Protein; Cholesterol; Chromatography, High Pressure Liquid; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase; Oxidation-Reduction; Pilot Projects; Renal Dialysis; Thioctic Acid; Treatment Outcome | 2007 |
Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Hypertension; Irbesartan; Linear Models; Lysine; Male; Middle Aged; Statistics, Nonparametric; Tetrazoles | 2008 |
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Proteinuria; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 2008 |
Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM.
Topics: Analysis of Variance; Arginine; Aspirin; Biopsy; Blood Glucose; Collagen; Cross-Linking Reagents; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Double-Blind Method; Glycated Hemoglobin; Lysine; Placebos; Skin | 1997 |
Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Captopril; Creatinine; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Lysine; Male; Neopterin; Predictive Value of Tests; Survival Analysis | 1998 |
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Analysis of Variance; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Myocardial Ischemia; Regression Analysis; Sensitivity and Specificity; Severity of Illness Index | 1998 |
Endocrinometabolic effects of whole versus segmental pancreas allotransplantation in diabetic patients--a two-year follow-up.
Topics: Adult; Arginine; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Pancreas Transplantation; Transplantation, Homologous | 1991 |
96 other study(ies) available for arginine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Humans; Methylamines; Oxides | 2022 |
Association of amino acids related to urea cycle with risk of diabetic nephropathy in two independent cross-sectional studies of Chinese adults.
Topics: Adult; Arginine; Citrulline; Cross-Sectional Studies; Diabetes Mellitus; Diabetic Nephropathies; Humans; Ornithine; Urea | 2022 |
Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
Topics: Arginine; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Diabetic Nephropathies; Heart Failure; Humans; Renal Insufficiency, Chronic | 2023 |
Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.
Topics: Arginine; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gastrointestinal Microbiome; Humans; Indican; Metabolomics; Sulfates | 2023 |
Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies.
Topics: Animals; Arginine; Diabetes Mellitus; Diabetic Nephropathies; Metabolome; Metabolomics; Mice; Network Pharmacology; Tandem Mass Spectrometry | 2024 |
ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus.
Topics: Amidohydrolases; Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Filtration Rate; Male; Mice; Mice, Inbred C57BL; Risk Factors; Streptozocin | 2019 |
Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
Topics: Adenoviridae; Albuminuria; Amidohydrolases; Animals; Arginine; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Genetic Therapy; Genetic Vectors; Inflammation Mediators; Kidney; Male; Mice, Inbred DBA; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Signal Transduction; Thiobarbituric Acid Reactive Substances | 2020 |
Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathy.
Topics: Adult; Aged; Albuminuria; Arginine; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Feasibility Studies; Female; Humans; Male; Middle Aged; Predictive Value of Tests; ROC Curve; Tandem Mass Spectrometry | 2020 |
A role for NPY-NPY2R signaling in albuminuric kidney disease.
Topics: Albuminuria; Animals; Arginine; Benzazepines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Doxorubicin; Humans; Insulin; Kidney Diseases; Kidney Glomerulus; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neuropeptide Y; Podocytes; Proteomics; Receptors, Neuropeptide Y; Signal Transduction | 2020 |
Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis.
Topics: Aged; Aged, 80 and over; Albuminuria; Apolipoproteins A; Apolipoproteins D; Arginine; Case-Control Studies; Diabetic Nephropathies; Female; Gene Expression; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Interleukin-6; Kidney; Lipopolysaccharides; Lipoproteins, HDL; Lysine; Macrophages; Male; Middle Aged; Primary Cell Culture; Protein Carbamylation; Proteome; Renal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha | 2020 |
Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury.
Topics: Adult; Albuminuria; Animals; Arginine; Asian People; Biomarkers; Cell Line; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibroblasts; Glomerular Mesangium; Glycated Hemoglobin; Humans; India; Male; Middle Aged; Rats | 2017 |
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
Topics: Albuminuria; Amidohydrolases; Animals; Arginine; Cell Proliferation; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Down-Regulation; Genetic Predisposition to Disease; Glomerular Mesangium; Glomerulonephritis; Hydrolysis; Kidney; Male; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Streptozocin | 2017 |
Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetic Nephropathies; Disease Progression; Female; Humans; Japan; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyruvaldehyde; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Up-Regulation | 2019 |
Protein arginine methyltranferase-1 induces ER stress and epithelial-mesenchymal transition in renal tubular epithelial cells and contributes to diabetic nephropathy.
Topics: Activating Transcription Factor 6; Animals; Apoptosis; Arginine; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Endoplasmic Reticulum Stress; Endoribonucleases; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Gene Expression Regulation; Glucose; Humans; Kidney Tubules; Mice; Mice, Knockout; Protein Serine-Threonine Kinases; Protein-Arginine N-Methyltransferases; Repressor Proteins | 2019 |
Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction.
Topics: Aged; Amidohydrolases; Arginine; Atherosclerosis; Cells, Cultured; Diabetic Nephropathies; Endothelial Cells; Female; Glycation End Products, Advanced; Humans; Male; Middle Aged; Nitric Oxide; Reactive Oxygen Species; Vascular Diseases | 2013 |
Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Arginine; Biomarkers; C-Reactive Protein; Case-Control Studies; Deoxyguanosine; Diabetic Nephropathies; Female; Humans; Inflammation; Interleukin-6; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Neopterin; Oxidative Stress; Tumor Necrosis Factor-alpha | 2014 |
[Recipient of living kidney transplantation during which heparin-induced thrombocytopenia (HIT) was suspected: a case report].
Topics: Aged; Anesthesia, General; Anticoagulants; Antithrombins; Arginine; Diabetic Nephropathies; Drug Substitution; Female; Heparin; Humans; Kidney Transplantation; Living Donors; Perioperative Care; Pipecolic Acids; Postoperative Complications; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2014 |
L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat.
Topics: Animals; Arginine; Citrulline; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Filtration Rate; Kidney; Kidney Glomerulus; Oxygen Consumption; Proteinuria; Rats | 2014 |
Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe³⁺: its potential role in prompt recognition of diabetes mellitus auto-antibodies.
Topics: Animals; Antigen-Antibody Complex; Arginine; Circular Dichroism; Comet Assay; Diabetes Mellitus; Diabetic Nephropathies; DNA; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Glyoxal; Humans; Leukocytes, Mononuclear; Microscopy, Fluorescence; Rabbits; Spectrophotometry, Ultraviolet | 2014 |
Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation.
Topics: Amino Acids; Animals; Arginase; Arginine; Blood Pressure; Citrulline; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Supplements; Fibronectins; Kidney; Male; Membrane Proteins; Mice; Mice, Inbred DBA; Nitrates; Nitric Oxide Synthase Type III; Nitrites; Tumor Necrosis Factor-alpha | 2014 |
Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
Topics: Aged; Albuminuria; Arginine; Biomarkers; Breath Holding; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Kidney; Male; Middle Aged; Outpatient Clinics, Hospital; Romania; Severity of Illness Index; Vasculitis, Central Nervous System | 2015 |
LC-MS/MS for the simultaneous determination of polar endogenous ADMA and CML in plasma and urine from diabetics.
Topics: Arginine; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Linear Models; Lysine; Retrospective Studies; Tandem Mass Spectrometry | 2015 |
The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes.
Topics: Albuminuria; Apolipoproteins; Apolipoproteins M; Arginine; Biological Transport; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Lipocalins; Lysophospholipids; Male; Middle Aged; Sphingosine; Triglycerides | 2015 |
Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Biopsy; Case-Control Studies; Collagen; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Female; Fluorescence; Humans; Longitudinal Studies; Lysine; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2016 |
Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
Topics: Aged; Arginine; Carotid Arteries; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renal Dialysis; Severity of Illness Index; Tunica Intima; Tunica Media; Ultrasonography | 2008 |
Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
Topics: Adenoviridae; Amidohydrolases; Animals; Arginine; Diabetic Nephropathies; Disease Models, Animal; Genetic Vectors; Ischemia; Kidney; Male; Nephritis, Interstitial; Nitric Oxide; Rats; Rats, Sprague-Dawley | 2009 |
Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes.
Topics: Adult; Aged; Albuminuria; Arginine; Biomarkers; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Humans; Japan; Male; Middle Aged; Nitric Oxide Synthase; Prognosis; Proportional Hazards Models; Prospective Studies | 2009 |
Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes.
Topics: Adolescent; Age of Onset; Albuminuria; Arginine; Biomarkers; Child; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; England; Epidemiologic Methods; Female; Glomerular Filtration Rate; Humans; Male; Prognosis | 2010 |
L-arginine and antioxidant diet supplementation partially restores nitric oxide-dependent regulation of phenylephrine renal vasoconstriction in diabetics rats.
Topics: Animals; Antioxidants; Arginine; Ascorbic Acid; Biopterins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Enzyme Inhibitors; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phenylephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vitamin E | 2010 |
Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Predictive Value of Tests; Young Adult | 2010 |
Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Chronic Disease; Diabetic Nephropathies; fas Receptor; Female; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Myostatin; Proteinuria; Ramipril | 2010 |
Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.
Topics: Aged; Amino Acids; Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Nitric Oxide; Reference Values | 2010 |
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
Topics: Aged; Arginine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged | 2011 |
Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats.
Topics: Animals; Arginine; Blood Glucose; Blood Urea Nitrogen; Body Weight; Caveolin 1; Cholesterol; Collagen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Fats; Endothelium, Vascular; Isoflavones; Kidney; Male; Nitric Oxide Synthase Type III; Nitrites; Organ Size; Proteinuria; Rats; Rats, Wistar; Sodium Nitrite; Urine | 2011 |
[Pentosidine].
Topics: Arginine; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Humans; Lysine | 2010 |
Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Blood Proteins; Chromatography, Liquid; Cystatin C; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Kynurenine; Male; Mass Spectrometry; Middle Aged | 2012 |
Renal protective effects of extracts from guava fruit (Psidium guajava L.) in diabetic mice.
Topics: Aldehyde Reductase; Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Blood Glucose; Blood Urea Nitrogen; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Fructose; Fruit; Hypoglycemic Agents; Insulin; Kidney; Lysine; Male; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; Psidium; Reactive Oxygen Species | 2012 |
Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice.
Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Endothelium, Vascular; Glucose; Kidney Glomerulus; Mice; Nitric Oxide Synthase Type III; Pterins | 2012 |
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Topics: Aged; Arginine; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Hyperlipidemias; Hypertension; Lysine; Male; Microvessels; Middle Aged; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Up-Regulation | 2013 |
ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
Topics: Adult; Aged; Amidohydrolases; Arginine; Cross-Sectional Studies; Czech Republic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Humans; Male; Methylation; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Reproducibility of Results; Risk Factors | 2012 |
Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Exenatide; Gene Expression Regulation, Enzymologic; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycation End Products, Advanced; Humans; Hypertrophy; Hypoglycemic Agents; Kidney; Kidney Glomerulus; Kidney Tubules; Macrophages; Male; Peptides; Protein-Arginine N-Methyltransferases; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Glucagon; Receptors, Immunologic; Repressor Proteins; RNA, Messenger; Venoms | 2013 |
Differential renal response to Nomega-nitro-L-arginine methyl ester and L-arginine in rats with hypertensive or diabetic nephropathy.
Topics: Animals; Arginine; Diabetic Nephropathies; Enzyme Inhibitors; Hemodynamics; Hypertension, Renal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 2002 |
Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications.
Topics: Amino Acid Substitution; Arginine; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Glycated Hemoglobin; Glycine; Humans; Male; Microcirculation; Mutation, Missense; Phenotype; Predictive Value of Tests; Regression Analysis; Superoxide Dismutase | 2003 |
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.
Topics: Arginine; Arteriosclerosis; Chlamydia Infections; Chlamydophila pneumoniae; Diabetic Nephropathies; Female; Genotype; Humans; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Oxidative Stress; Peroxidase; Polymorphism, Single Nucleotide; Risk Factors | 2003 |
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles | 2003 |
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Topics: Adult; Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Morbidity; Nitric Oxide Synthase | 2004 |
Dissociation between urinary pyrraline and pentosidine concentrations in diabetic patients with advanced nephropathy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arginine; beta 2-Microglobulin; Biomarkers; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Humans; Lysine; Pyrroles; Reference Values; Regression Analysis | 2004 |
Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged | 2004 |
Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients.
Topics: Amino Acid Substitution; Arginine; Cross-Sectional Studies; Cysteine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Exons; Female; Genotype; Glycine; Humans; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serine | 2005 |
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
Topics: Alternative Splicing; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Blotting, Western; Cattle; Cells, Cultured; Collagen; Diabetic Nephropathies; DNA Primers; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Immunohistochemistry; Immunoprecipitation; Kidney Cortex; Lysine; Male; Microscopy, Fluorescence; Molecular Weight; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Skin; Time Factors; Up-Regulation | 2005 |
Vascular effects of the human extracellular superoxide dismutase R213G variant.
Topics: Amino Acid Substitution; Animals; Arginine; Diabetic Nephropathies; Disease Models, Animal; Gene Transfer Techniques; Glycine; Humans; Kidney Failure, Chronic; Male; Myocardial Ischemia; Polymorphism, Single Nucleotide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Recombinant Proteins; Superoxide Dismutase | 2005 |
Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy.
Topics: Aldehydes; Arginine; Binding Sites; Cell Adhesion; Cell Physiological Phenomena; Collagen Type IV; Diabetic Nephropathies; Endothelial Cells; Extracellular Matrix; Extracellular Matrix Proteins; Glucose; Glyoxal; Humans; Integrin alphaVbeta3; Integrins; Kidney; Kidney Glomerulus; Pyridoxamine; Pyruvaldehyde; Umbilical Veins | 2005 |
In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy.
Topics: Animals; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Fat-Restricted; Disease Models, Animal; Female; Follow-Up Studies; Glycation End Products, Advanced; Immunohistochemistry; Kidney; Lysine; Male; Microscopy, Electron; Obesity; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar | 2005 |
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzimidazoles; Benzoates; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Endothelium, Vascular; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Oxidative Stress; Randomized Controlled Trials as Topic; Renal Insufficiency; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |
Synergistic association of metabolic syndrome and overt nephropathy with elevated asymmetric dimethylarginine in serum and impaired cutaneous microvasodilation in patients with type 2 diabetes.
Topics: Albuminuria; Arginine; Cholesterol, HDL; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Foot; Hot Temperature; Humans; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Thrombomodulin; Vasodilation | 2006 |
Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats.
Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Inhibitors; Kidney Glomerulus; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Proteinuria; Rats; Rats, Inbred OLETF; Time Factors | 2006 |
Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.
Topics: Aged; Albuminuria; Arginine; Atherosclerosis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2007 |
[Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lipoproteins, LDL; Lysine; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors | 2007 |
Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability.
Topics: alpha-Tocopherol; Animals; Antioxidants; Arginase; Arginine; Blood Pressure; Cationic Amino Acid Transporter 2; Cell Hypoxia; Citrulline; Diabetic Nephropathies; Glomerular Filtration Rate; Kidney Medulla; Liver; Male; Nitric Oxide; Ornithine; Oxidative Stress; Oxygen; Rats; Rats, Inbred WF; Regional Blood Flow | 2008 |
Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model.
Topics: Animals; Antimutagenic Agents; Arginine; Basic Helix-Loop-Helix Transcription Factors; Blood Pressure; Blotting, Western; Chromatography, High Pressure Liquid; Cobalt; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Gene Expression; Glycation End Products, Advanced; Hypertension; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immediate-Early Proteins; Insulin-Like Growth Factor Binding Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Lysine; Male; NADPH Oxidases; Obesity; Oxidative Stress; Polymerase Chain Reaction; Rats; Rats, Inbred SHR; RNA, Messenger; Transforming Growth Factor beta | 2008 |
Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2008 |
Oxidative stress and cellular stress response in diabetic nephropathy.
Topics: Aldehydes; Arginine; Chaperonin 60; Diabetic Nephropathies; F2-Isoprostanes; Female; Heat-Shock Response; Heme Oxygenase-1; HSP70 Heat-Shock Proteins; Humans; Lymphocytes; Lysine; Male; Middle Aged; Oxidative Stress; Protein Carbonylation; Renal Insufficiency; Thioredoxin Reductase 1 | 2007 |
Inhibition of arginine- and hypoglycemia- induced growth hormone release by acetate in dialyzed patients.
Topics: Acetates; Adult; Aged; Arginine; Diabetic Nephropathies; Female; Growth Hormone; Humans; Hypoglycemia; Male; Middle Aged; Renal Dialysis; Uremia | 1982 |
Acetate suppresses growth hormone secretion in uremic patients: hemodialysis and acetate infusion experiments.
Topics: Acetates; Adult; Arginine; Blood Glucose; Depression, Chemical; Diabetic Nephropathies; Female; Growth Hormone; Humans; Infusions, Parenteral; Male; Middle Aged; Renal Dialysis; Stimulation, Chemical; Uremia | 1982 |
Plasma pentosidine levels in uremic patients before and after hemodialysis.
Topics: Arginine; beta 2-Microglobulin; Cross-Linking Reagents; Diabetic Nephropathies; Glycosylation; Humans; Kidney; Kidney Failure, Chronic; Lysine; Metabolic Clearance Rate; Renal Dialysis; Uremia | 1995 |
Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease.
Topics: Arginine; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Linear Models; Lysine; Male; Middle Aged; Peritoneal Dialysis; Peritoneum; Renal Dialysis; Skin | 1995 |
Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
Topics: Animals; Arginine; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Hemodynamics; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Rats; Rats, Sprague-Dawley; Reference Values; Regional Blood Flow; Renal Circulation | 1994 |
Beta-cell dysfunction following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Eating; Glucagon; Humans; Immunosuppression Therapy; Islets of Langerhans; Pancreas Transplantation; Reference Values | 1994 |
L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats.
Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Kidney; Nitric Oxide; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation | 1993 |
Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.
Topics: Adult; Age Factors; Arginine; Collagen; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Sex Factors; Time Factors | 1993 |
Effects of kidney or kidney-pancreas transplantation on plasma pentosidine.
Topics: Adult; Arginine; Diabetic Nephropathies; Female; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Male; Middle Aged; Models, Chemical; Pancreas Transplantation; Time Factors | 1993 |
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Maillard Reaction; Male; Microcirculation; Middle Aged; Skin | 1993 |
Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine.
Topics: Animals; Arginine; beta 2-Microglobulin; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet; Glomerulonephritis; Humans; Kidney Failure, Chronic; Lysine; Maillard Reaction; Nephrectomy; Oxidation-Reduction; Protein Binding; Rats; Rats, Wistar; Serum Albumin; Uremia | 1996 |
Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats.
Topics: Acute Kidney Injury; Analysis of Variance; Animals; Arginine; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ischemia; Nephrectomy; Nitrates; Nitric Oxide; Nitrites; Nitroarginine; Rats; Rats, Wistar; Reference Values; Renal Artery; Renal Circulation; Sodium | 1996 |
Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in the diabetic kk mouse.
Topics: Albuminuria; Animals; Arginine; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glucose; Glycosylation; Hydroxyl Radical; Kidney; Lipid Peroxidation; Mice; Mice, Inbred Strains; Nitric Oxide; Organ Size; Oxidation-Reduction | 1997 |
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Aorta; Arginine; Diabetic Nephropathies; Erythrocytes; Female; Glycation End Products, Advanced; Humans; Imidazoles; Immunohistochemistry; Kidney; Male; Middle Aged | 1997 |
Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes.
Topics: Animals; Antibodies, Monoclonal; Arginine; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycation End Products, Advanced; Imidazoles; Kidney; Kinetics; Maillard Reaction; Male; Mice; Rats; Rats, Wistar | 1997 |
High glucose inhibits nitric oxide production in cultured rat mesangial cells.
Topics: Amino Acids; Animals; Arginine; Cells, Cultured; Diabetic Nephropathies; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Rats | 1997 |
Kinetic analysis of furosine and pentosidine in CAPD patients.
Topics: Adult; Arginine; Chromatography, High Pressure Liquid; Diabetes Mellitus; Diabetic Nephropathies; Dialysis Solutions; Glycation End Products, Advanced; Humans; In Vitro Techniques; Kidney Failure, Chronic; Lysine; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Proteins; Renal Dialysis | 1997 |
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Animals; Antibodies; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Kidney Glomerulus; Lipid Peroxidation; Lysine; Male; Malondialdehyde; Mice; Middle Aged; Nephrotic Syndrome; Norleucine; Pyrroles; Rabbits | 1997 |
Alterations in cholesteryl ester transfer, lipoprotein lipase, and lipoprotein composition after combined pancreas-kidney transplantation.
Topics: Adult; Arginine; Carrier Proteins; Cholesterol Ester Transfer Proteins; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glycoproteins; Humans; Hyperinsulinism; Injections, Subcutaneous; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Pancreas Transplantation; Phosphorus; Transplantation, Homologous | 1998 |
Trp64Arg mutation of beta3-adrenoceptor gene is associated with diabetic nephropathy in Type II diabetes mellitus.
Topics: Aged; Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Mutation; Receptors, Adrenergic, beta; Tryptophan | 1998 |
Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.
Topics: Adult; Aged; Aldehyde Reductase; Arginine; Creatinine; Deoxyglucose; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Glycation End Products, Advanced; Hemoglobins; Humans; Imidazoles; In Vitro Techniques; Lysine; Male; Middle Aged; Polymers; Renal Dialysis; Sorbitol; Uremia | 1999 |
Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
Topics: Albuminuria; Arginine; Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; Reference Values | 1999 |
Is Trp64Arg polymorphism of beta3-adrenergic receptor a clinically useful marker for the predisposition to diabetic nephropathy in Type II diabetic patients?
Topics: Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Genetic Markers; Humans; Receptors, Adrenergic, beta; Tryptophan | 1999 |
Trp64Arg polymorphism of the beta3-adrenergic receptor is not associated with diabetic nephropathy in Japanese patients with type 2 diabetes.
Topics: Albuminuria; Amino Acid Substitution; Arginine; Asian People; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Genotype; Humans; Japan; Male; Middle Aged; Polymorphism, Genetic; Proteinuria; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Tryptophan | 2000 |
Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Topics: Adult; Antibodies; Arginine; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Diseases; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reference Values; RNA, Messenger | 2000 |
Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes.
Topics: Adult; Aged; Arginine; beta 2-Microglobulin; Biocompatible Materials; Blood Pressure; Diabetic Nephropathies; Female; Hematocrit; Hemodiafiltration; Hemoglobins; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Male; Membranes, Artificial; Middle Aged; Renal Dialysis; Urea | 2001 |
Tetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells.
Topics: Animals; Arginine; Ascorbic Acid; Biopterins; Cell Division; Cells, Cultured; Diabetic Nephropathies; Enzyme Induction; Glomerular Mesangium; Glucose; Mice; Models, Chemical; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II | 2001 |
N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.
Topics: Animals; Arginine; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Mesangium; Glycation End Products, Advanced; Kidney; Kidney Glomerulus; Lysine; Mice; Mice, Inbred C57BL; Proteinuria; Thiazoles | 2001 |
Daily haemodialysis improves indices of protein glycation.
Topics: Adult; Aged; Arginine; Circadian Rhythm; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Longitudinal Studies; Lysine; Male; Middle Aged; Molecular Weight; Prospective Studies; Renal Dialysis | 2002 |
Renal function changes in diabetes.
Topics: Antihypertensive Agents; Arginine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glomerular Filtration Rate; Glucose; Humans; Insulin; Kidney; Kidney Function Tests; Kidney Glomerulus; Lysine; Male; Organ Size; Proteinuria | 1976 |
Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.
Topics: Adult; Arginine; Collagen; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Models, Biological; Reference Values; Skin; Skin Aging | 1992 |
First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Kidney Transplantation; Pancreas Transplantation | 1991 |
Studies of pancreatic alpha cell function in normal and diabetic subjects.
Topics: Adolescent; Adult; Arginine; Body Weight; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Diabetic Nephropathies; Fasting; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Middle Aged; Pancreas; Radioimmunoassay | 1970 |
[Behavior of blood ammonia in liver patients treated with arginine-glucose-1-phosphate].
Topics: Adult; Aged; Alcoholism; Ammonia; Arginine; Diabetic Nephropathies; Female; Glucose; Hepatitis; Humans; Jaundice; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Phosphates | 1967 |